Cargando…
RUNX represses Pmp22 to drive neurofibromagenesis
Patients with neurofibromatosis type 1 (NF1) are predisposed to develop neurofibromas, but the underlying molecular mechanisms of neurofibromagenesis are not fully understood. We showed dual genetic deletion of Runx1 and Runx3 in Schwann cells (SCs) and SC precursors delayed neurofibromagenesis and...
Autores principales: | Hall, Ashley, Choi, Kwangmin, Liu, Wei, Rose, Jonathan, Zhao, Chuntao, Yu, Yanan, Na, Youjin, Cai, Yuqi, Coover, Robert A., Lin, Yi, Dombi, Eva, Kim, MiOk, Levanon, Ditsa, Groner, Yoram, Boscolo, Elisa, Pan, Dao, Liu, P. Paul, Lu, Q. Richard, Ratner, Nancy, Huang, Gang, Wu, Jianqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6482019/ https://www.ncbi.nlm.nih.gov/pubmed/31032403 http://dx.doi.org/10.1126/sciadv.aau8389 |
Ejemplares similares
-
Runx1: a new driver in neurofibromagenesis
por: Wu, Jianqiang, et al.
Publicado: (2015) -
Author reply to: RUNX3 is expressed in the epithelium of the gastrointestinal tract
por: Levanon, Ditsa, et al.
Publicado: (2012) -
Runx3-mediated Transcriptional Program in Cytotoxic Lymphocytes
por: Lotem, Joseph, et al.
Publicado: (2013) -
Developmentally regulated promoter-switch transcriptionally controls Runx1 function during embryonic hematopoiesis
por: Pozner, Amir, et al.
Publicado: (2007) -
Runx3 prevents spontaneous colitis by directing the differentiation of anti-inflammatory mononuclear phagocytes
por: Hantisteanu, Shay, et al.
Publicado: (2020)